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Abstract
Background: Comparative studies on the response of neonates and adults to TLR stimulation have been almost exclusively
limited to comparisons of human neonatal cord blood cells with peripheral blood from adults, and analyses of spleen cell
responses in mice. We need to extend these studies and gain further information regarding such responses at mucosal sites.
Methodology/Principal Findings: We used sheep as a large animal model to study TLR agonist responses in the lymph
nodes draining the intestine, an organ that must adapt to profound changes after birth. In response to the imidazoquinoline
compound R-848, neonatal mesenteric lymph node (MLN) and spleen cells produced more IL-12 and, consequently, more
IFNc than their adult counterparts. This difference was age-related for both organs, but the preferential IL-12 response
decreased more rapidly in the MLN, with young animals producing similar amounts of this cytokine to adults, from the age
of 20 days onwards. Intracellular assays and depletion experiments identified CD14
+CD11b
+CD40
+ cells as the main
producer of IL-12. These cells accounted for a greater proportion of neonatal than of adult MLN cells, and also produced, in
direct response to R-848, more IL-12 after isolation. This strong IL-12 response in neonates occurred despite the production
of larger amounts of the regulatory cytokine IL-10 and the stronger upregulation of SOCS-1 and SOCS-3 mRNA levels than in
adult cells, and was correlated with an increase in p38/MAPK phosphorylation.
Conclusions/Significance: This is the first attempt to decipher the mechanism by which neonatal MLN cells produce more
IL-12 than adult cells in response to the TLR8 agonist R-848. CD14
+CD11b
+CD40
+ IL-12-producing cells were more
numerous in neonate than in adult MLN cells and displayed higher intracellular responsiveness upon R-848 stimulation. This
work provides relevant information for future vaccination or immunostimulation strategies targeting neonates.
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Introduction
Children and young animals are more vulnerable to infections
because their immune system is still developing and differs in
several ways from that of adults. This higher level of susceptibility
has often been attributed to differences in the number, phenotype
and/or impaired functions of cells from both innate and adaptive
immune compartments. However, in certain circumstances, the
innate immune cells of neonates may be more responsive to
cytokine stimuli or microbial ligands [1–4]. It is therefore
important to identify these specific features, with a view to
developing new strategies for boosting the neonatal immune
system to improve disease control.
In both humans and mice, neonates have a diminished capacity
to mount the Th1-type responses involved in controlling
intracellular pathogens [5–7]. TLRs are innate immune receptors
involved in pathogen recognition and their agonists are widely
used in vaccination and immunostimulation strategies for
promoting Th1 polarisation [8–10]. Several studies have investi-
gated the specific features of neonatal antigen-presenting cell
(APC) responses to TLR ligands in mice and humans. In mice,
these studies have been performed on spleen APCs, because the
rates of recovery of APCs from other lymphoid organs and
peripheral blood are low. It has been shown that neonatal splenic
macrophages stimulated with various agonists of TLR-2, -4 and -9
produce fewer proinflammatory cytokines than adult cells, due to
excessive IL-10 secretion [11,12]. By contrast, isolated neonatal
murine splenic CD11c
+ DCs produce even more IL-12p70 than
their adult counterparts after TLR stimulation [13]. In humans,
stimulation of most of the TLRs on cord blood-derived monocytes
and APCs results in the impaired production of various cytokines
supporting Th1-type responses, including TNFa and IL-12,
together with a strong production of IL-6, IL-10 and IL-23,
polarising the immune response towards the Th17 and Th2
pathways [1,14–16]. By contrast, TLR8 agonists seem to be
uniquely effective to induce Th1-polarizing cytokine production
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candidate adjuvants for enhancing the immune responses in
newborns [1]. In ruminants, TLR8 agonists are also highly
effective at inducing IFNc release by peripheral blood monocytes
[17]. Consistent with this finding, we observed that the TLR8
agonist R-848 induced a preferential Th1-type cytokine response
in neonatal goat cells in intestinal draining lymph nodes [18],
although the mechanism underlying this preferential response was
not elucidated and merits further investigation. Large animal
models, allowing the isolation of sufficient numbers of cells from
newborn animals only a few days old, are of particular interest for
studying TLR responses at mucosal sites.
In this study, we investigated the in vitro cytokine response of
ovine mesenteric lymph nodes (MLN) and spleen cells isolated at
different ages to the promising TLR8 synthetic agonist R-848. We
found that neonatal cells produced more IL-12 than adult cells.
This difference was age-related, with MLN and spleen cells
displaying different response kinetics. CD14
+ cells were identified
as the main producers of IL-12, and the neonatal IL-12 secretion
observed in response to R-848 was shown to be related to
differences affecting both the proportions of these cells and the
qualitative response of the downstream intracellular signalling
pathway, involving, in particular, the level of p38/MAPK
phosphorylation.
Materials and Methods
Animals and cell isolation
The Pre ´alpes adult sheep, neonates (aged 6 to 14 days) and 20-
day-old lambs used in this study were reared in conventional but
protected sanitary facilities (PFIE, INRA, F-37380 Nouzilly,
France). Newborn lambs were not separated from their mothers
until one day after birth, to allow them to suckle colostrum, and
were then fed ad libitum with reconstituted milk. Experimental
protocols were designed in compliance with French law (De ´cret
2001-464 29/05/01) and EEC regulations (86/609/CEE) con-
cerning the care and use of laboratory animals. Euthanasia was
performed after electric stunning according to the AMVA
guideline (2007) on euthanasia. Lymph nodes and spleen were
removed from euthanasied animals at INRA-Nouzilly slaughter-
house with the consent from the slaughterhouse.Cells from freshly
removed MLN or spleen were isolated as previously described
[18]. Briefly, cells were isolated by mechanical dissociation of the
tissue on 200 mm pore nylon gauze and then passed through a
nylon mesh with 60 mm pores. Mononuclear cells were finally
obtained after centrifugation over a Histopaque gradient.
Reagents
PolyI:C, Resiquimod (R-848), Gardiquimod, CL075 and
CL087 were purchased from Invivogen (Toulouse, France).
PMA and ionomycin were purchased from Sigma. Recombinant
human TGFb1 was obtained from AbD Serotec (Oxford, UK).
Recombinant ovine IL-12 and IL-10 were kindly provided by S.
Wattegedera (Moredun Research Institute, Edinburgh, UK).
TLR agonist stimulation and cytokine quantification by
ELISA
MLN or spleen cells were stimulated, at a density of 1.5610
6/
ml in complete RPMI 1640 medium (Gibco-Invitrogen, Cergy-
Pontoise, France) supplemented with 10% FCS, 100 IU/ml
penicillin, 100 mg/ml streptomycin sulfate and 50 mM b-mercap-
toethanol (Merck Chemicals Ltd., Nottingham, UK) with polyI:C
(12.5 mg/ml), R-848 (0.5 mg/ml), Gardiquimod (5 mg/ml), CL075
(0.5 mg/ml) or CL087 (0.5 mg/ml). Non-specific stimulation was
performed with a mixture of PMA (50 ng/ml) and ionomycin
(500 ng/ml). In some experiments, rhTGFb1 or rovIL-10 was
added to MLN cells at the same time as R-848. Culture
supernatants were harvested and stored at -20uC until assayed
for the detection of cytokines by ELISA. Intracellular staining for
IL-12 was performed on MLN cells cultured in complete RPMI
medium with or without R-848 for 8 h. Brefeldin A (Sigma) was
added to the cells at a concentration of 5 mg/ml, for the last 5 h of
culture. In the IL-12 neutralisation assay, mouse anti-bovine IL-12
(clone CC301, AbD Serotec) was added, at a concentration of
10 mg/ml, at the same time as the TLR agonists. In some
experiments, the medium culture was supplemented with 10%
neonatal autologous plasma or 10% adult plasma instead of 10%
FCS as stated above. For p38/MAPK inhibition, 20 mMo f
SB203580 was added at the beginning of the culture.
Pairs of antibodies against bovine cytokines were obtained from
AbD Serotec and have been shown to recognise ovine IL-12
[19,20], IFNc [21] and IL-10 [20,22]. ELISA was carried out as
previously described [18]. Antibody pairs used for IL-12 ELISA
cannot distinguish between IL-12p70 and the IL-12p40 subunit
but have been shown to both block the biological activity of the
cytokine [19]. Incubations were performed at 37uC for IL-10 and
at room temperature for the other ELISA.
Cell sorting and flow cytometry
A high-speed MoFlo cell sorter (Dako, Trappes, France) was
used to sort freshly isolated total MLN cells. In these experiments,
cells were labelled with a mouse antibody specific for ovine CD14
(clone CAM36A, VMRD, Pullman, USA) and stained with a
fluorochrome-conjugated goat anti-mouse immunoglobulin anti-
body (Caltag-Invitrogen). As CD14 displays intermediate levels of
expression by lymph granulocytes in sheep [23], CD14
+ cell
sorting was always performed after gating on non-granulocytic
MLN cells according to SSC/FSC analysis, although most
granulocytes were discarded on the Histopaque gradient. Both
CD14
+ and CD14
2 cell fractions were cultured in vitro at a density
of 1.5610
6/ml (3.10
5/well), with and without R-848, or were
directly analysed by qRT-PCR.
For the intracellular staining of IL-12, surface staining was first
carried out with the following purified monoclonal antibodies
directed against ovine markers: CD11b (clone MM12A, VMRD),
CD14 (clone CAM36A, VMRD), MHC class II (clone 28.1, AbD
Serotec) and CD205 (clone CC98, AbD Serotec). Fixed and
permeabilised cells were then incubated with the mouse anti-
bovine/ovine IL-12 antibody (clone CC301, AbD Serotec).
For characterisation of the CD14
+ cell phenotype, total MLN
cells were double-labelled with an anti-ovine CD14 (clone TU ¨K4,
AbD Serotec) and an anti-CD11b (clone MM12A) or anti-CD11c
(clone BAQ153A) antibody (both purchased from VMRD), or
antibodies against CD26 (clone CC69), CD205 (clone CC98),
MHC class II molecules (clone 28.1) (all from AbD Serotec), or
against CD206 (clone 3.29B1.10, Beckman Coulter, Villepinte,
France) or CD40 (clone ILA156 originally produced by J.
Naessens (ILRAD, Nairobi, Kenya)). Flt3 (CD135) expression
was determined by incubating cells with a His6-tagged porcine Flt3
ligand, and labelling with an anti-His6-tag monoclonal antibody,
as previously described [24].
Every staining reaction described in this section was followed by
further incubation with fluorochrome-conjugated goat anti-mouse
immunoglobulin isotype antibodies (Caltag-Invitrogen). Isotype-
matched antibodies were used as controls. Cells were finally
analysed with a FACS-Calibur
TM flow cytometer (BD Instru-
ments, San Jose, USA) equipped with CellQuest ProH software.
Age-Dependent Response to R848
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RNA was extracted with the NucleoSpin RNA II kit (Macherey-
Nagel, Hoerdt, France), according to manufacturer’s instructions
and quantified using Nanodrop (Thermo Fisher Scientific,
Courtaboeuf, France). Purified RNA was reverse-transcribed using
oligo(dT) primers and M-MLV reverse transcriptase (Promega,
Charbonnie `res-les-Bains, France). Couples of primers were
designed on different exons using Primer 3 software to avoid
DNA amplification (Table S1) and for each couple of primers, all
qPCRs displayed efficiency between 90% and 110%. Diluted
cDNA was combined with primers and IQ SYBRGreen Supermix
(Bio-Rad, Hercules, USA) according to the manufacturer’s
recommendations and real-time assays were run on a Bio-Rad
Chromo 4 (Bio-Rad). The specificity of the qPCR reactions was
assessed by analysing the melting curves of the products and size
verification of the amplicons. To minimise sample variations, we
used identical number of cells and high quality RNA. Hypoxan-
thine phosphoribosyltransferase (HPRT) mRNA levels were used
to normalise RNA quantification.
Electron microscopy
Sorted CD14
+ cells were fixed, post-fixed and dehydrated in a
graded series of ethanol solutions. Cell pellets were embedded in
Epon resin (Sigma). Ultrathin sections were cut, stained and
deposited on electron microscopy grids coated with collodion
membrane for examination under a Jeol 1010 transmission
electron microscope (Jeol, Croissy-sur-Seine, France). For scan-
ning electron microscopy, sorted CD14
+ cells were incubated
overnight in complete RPMI medium on glass coverslips. After
fixation and post-fixation processes, samples were dehydrated in
graded acetone solutions, dried to the critical point under CO2
and coated by gold sputtering before examination in an FEG
Gemini 982 scanning electron microscope (Carl Zeiss, Nanterre,
France).
p38/MAPK phosphorylation analysis by western blotting
Sorted MLN CD14
+ cells were incubated overnight, at a density
of 1.5610
6/ml, in complete RPMI medium and were then starved
by incubation for 2 h in RPMI alone. They were collected after
stimulation with R-848 for 15 or 30 minutes, or as unstimulated
cells. We resolved the lysates of 1610
6 cells on a 12% acrylamide
gel by SDS-PAGE and transferred the resulting bands onto
nitrocellulose membranes. The saturated blots were probed
overnight with a primary rabbit IgG antibody directed against
phosphorylated (Thr180/Tyr182) human p38/MAPK (1/1000,
Cell Signaling Technology-Ozyme, Saint Quentin en Yvelines,
France) and were then incubated with horseradish peroxidase-
conjugated anti-rabbit IgG (1/2000, Cell Signaling Technology-
Ozyme). The specific signals were visualised by chemilumines-
cence, with the LumigloH substrate system (Cell Signaling
Technology-Ozyme). Blots were then stripped and reprobed as
described above, but with a primary rabbit polyclonal IgG specific
for human total p38/MAPK (1/1000, Cell Signaling Technology-
Ozyme). Phosphorylated p38/MAPK (pp38) levels were quanti-
fied relative to total p38/MAPK protein levels, with Scion
software.
Results
Strong IL-12 and IFNc response of neonatal MLN cells in
response to TLR agonists
Various cytokine responses to TLR agonists have been described
in cells isolatedfrom the systemic compartment [1,25–27], but these
responses have not been studied in cells isolated from lymph nodes
draining the intestinal mucosa with exception to our previous work
on caprines [18]. We continued this work in ovine for practical
reasons to further dissect the cellular mechanism involved in TLR
agonist response in MLN. Cells isolated from neonatal and adult
sheep were stimulated in vitro with polyI:C (TLR3 agonist),
Resiquimod (also called R-848) and Gardiquimod (both agonists
of TLR7/8) for 48 h, and cytokine levels were determined by
ELISA. Neonatal MLN cells produced variable amounts of IL-12
(Fig. 1A) and IFNc (Fig. 1B), but the amounts produced were
significantly largerthan those produced by adult MLN cells,with R-
848 and Gardiquimod being the best inducers. However, adult
MLN cells were not intrinsically deficient for IFNc production
compared to neonatal cells, as they produced significantly larger
amounts of this cytokine in responseto non-specific stimulationwith
PMA associated with ionomycin in vitro (Fig. 1C). Moreover, by
neutralising the IL-12 in vitro, we showed that IL-12 made a major
contribution to IFNc production by neonatal cells (7369%
inhibition, p,0.05). The IL-12 ELISA used cannot distinguish
between IL-12p70 and the p40 chain, however this data suggests
that MLN cells of neonates produce more bioactive IL-12 in
response to R-848. We therefore investigated the particular features
of the neonatal cells producing IL-12 in our model.
Neonatal cells highly expressed IL-12p40, IL-12p35 and
IL-23p19 chains upon R-848 stimulation
IL-12 and IL-23 are heterodimeric cytokines of the IL-12 family
that share the p40 chain. Defective IL-12 production, associated
with an increase in IL-23 production, has been reported in human
neonatal cells stimulated with TLR ligands [15]. As no ELISA for
IL-23 is yet available for sheep, we investigated the levels of
mRNA for the IL-12- and IL-23-specific chains, p35 and p19,
respectively, and those for their common chain, p40, by
quantitative RT-PCR, to identify putative differences in the
expression of these cytokines between adults and neonates. We
decided to focus on the TLR agonist R-848, as this molecule was
the strongest inducer of IL-12 in vitro. Consistent with our ELISA
findings for IL-12 (Fig. 1), qRT-PCR on MLN cells stimulated
with R-848 showed that IL-12p40 and IL-12p35 mRNA levels
were about 50 and four times higher, respectively, in neonatal cells
than in their adult counterparts, 3 h after stimulation (Fig. 2A, 2B).
Strong IL-23 mRNA expression was observed only in neonates
(Fig. 2C), suggesting that, in response to R-848 stimulation,
neonatal MLN cells produced not only more IL-12, but also
possibly more IL-23, than did adult cells.
The stronger IL-12 response of neonatal MLN cells rapidly
weakens with age
We investigated whether the stronger production of IL-12 by
neonatal MLN cells evolved rapidly with age, by comparing the
IL-12 secretion of MLN cells from 20-day-old lambs with that of
neonatal lambs and adult sheep. We found that, in response to in
vitro R-848 stimulation, the initially high level of IL-12 secretion by
neonatal MLN cells rapidly decreased as the animal aged, with
cells from 20-day-old lambs producing as little IL-12 as adult cells
(Fig. 3A). By contrast, the IL-12 secretion of splenocytes isolated
from 20-day-old lambs, although quantitatively variable, remained
significantly stronger than that of adult cells (Fig. 3B). Thus, the
higher IL-12 response began to decline earlier in MLN cells than
in spleen cells, suggesting major changes in TLR responsiveness in
the lymph nodes within the first few days of life. Furthermore, the
strong IL-12 response of neonatal cells was detected not only in the
intestinal draining lymph nodes, but also in the systemic
compartment.
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associated with regulatory cytokines TGFb1 and IL-10
We investigated the effect of two regulatory cytokines widely
expressed in the lymphoid tissues associated with the intestine,
TGFb1 and IL-10, on IL-12 production by neonatal and adult
MLN cells. rhTGFb1, despite its cross-reactivity and its suppressive
effecton ovine cells(data not shown),had no significanteffecton the
response to R-848 (Fig. 4A). By contrast, IL-10 had a regulatory
effect, as at a concentration of 25 IU/ml, it almost completely
abolished IL-12 secretion by the MLN cells of both neonates and
adults (Fig. 4B). We therefore investigated whether IL-10 in adult
wasproducedinlargeramountsinthe intestineorMLN,potentially
accounting for lower IL-12 response observed to R-848 stimulation.
However, at homeostasis, IL-10 mRNA levels were similar in the
MLN (Fig. 4C), such as for jejunum and Peyer’s patch samples (data
not shown). Following stimulation in vitro with R-848, neonatal cells
producedlowquantitiesbutsignificantlymore IL-10thanadultcells
(Fig. 4D). Thus, despite the presence of detectable, but low levels, of
IL-10 after R-848 stimulation, neonatal MLN cells produced more
IL-12 than adult MLN cells. Regulatory T cells (Treg) are known to
produce regulatory cytokines like IL-10 and TGFb. To date, no
antibody is available in sheep to characterise this cell population
with the specific marker Foxp3. We therefore investigated the
expression level of the transcription factor Foxp3 by real-time RT-
PCR in neonate and adult MLN cells but found no significant
differenceinthelevel of expression (Fig4E).Levy et al. observed that
newborn plasma conferred substantially reduced BLP-, LPS-, and
imiquimod-induced TNF-a release by adult monocytes [28].
However, it has to be noticed that the same authors did not
observed similar effect of neonatal plasma on R-848-induced TNF-
a release [28]. These results suggest that soluble factors in the
plasma present in different concentrations in neonates and adults
could affect differentially the IL-12 response. We therefore analysed
the response of neonate MLN cells to R-848 in vitro in presence of
Figure 1. Comparative IL-12 and IFNc responses of neonatal and adult MLN cells following TLR agonist stimulation. Neonatal (closed
circles) and adult (open squares) MLN cells were cultured in vitro with or without 12.5 mg/ml polyI:C, 0.5 mg/ml R-848 or 5 mg/ml Gardiquimod.
Supernatants were harvested after 48 h of culture and ELISA was carried out for IL-12 (A) and IFNc (B) secretion. Non-specific cell stimulation was also
carried out with 50 ng/ml PMA combined with 500 ng/ml ionomycin, with the supernatants assayed for IFNc detection 48 h later (C). Each circle or
square represents one neonate or one adult, respectively. Medians are shown for each stimulus. Non-parametric Mann-Whitney tests were used to
compare data for neonates and adults: *p#0.01; **p#0.005; ***p#0.001; ****p#0.0005.
doi:10.1371/journal.pone.0013705.g001
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reduced in 10% plasma compared to 10% FCS, but we did not
observed any significant difference in the IL-12 levels released by
neonatal cells cultivated with 10% neonate or adult plasma (Fig 4F).
CD14
+ and CD11b
+ cells make a major contribution to IL-
12 secretion in response to R-848
For a more precise characterisation of the mechanisms
governing these differences in IL-12 secretion between neonates
and adults, we needed to identify the principal cell population
responsible for secreting this cytokine in the neonatal MLN.
ELISA kinetic assays showed that IL-12 secretion by neonatal
MLN cells was induced rapidly, as it was detected as soon as 3 h
after R-848 stimulation, with this cytokine continuing to
accumulate until 28 h after stimulation (Fig. 5A), consistent with
the findings for IL-12p40 and p35 mRNA levels (Fig. 2). We
therefore added brefeldin A to neonatal MLN cells 3 h after
stimulation with R-848 and incubated the cells with this
compound for 5 h. Cells were then harvested for IL-12
intracellular staining combined with the labelling of several
potential APC markers in the ovine model. Both CD14
+ cells
and CD11b
+ cells made major contributions to IL-12 secretion in
response to R-848 (Fig. 5B).
CD14
+ cells co-express CD11b and CD40 and have long
dendritic processes
We characterised the cell population expressing IL-12 further,
by double staining neonatal CD14
+ cells from the MLN (Table 1).
Figure 2. Levels of mRNA for IL-12/IL-23p40, IL-12p35 and IL-23p19 chains in MLN cells after R-848 stimulation. Neonate (black bars)
and adult (white bars) MLN cells were cultured in vitro with or without 0.5 mg/ml R-848. At each time point, cells were recovered and mRNA levels for
IL-12/IL-23p40 (A), IL-12p35 (B) and IL-23p19 (C) chains were determined by quantitative RT-PCR. After normalisation with the HPRT housekeeping
gene, the data are shown as mean 6 SEM values for the ratio of stimulated to resting cells.
doi:10.1371/journal.pone.0013705.g002
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+ cells also expressed CD11b. Moreover, all
CD11b
+ cells co-expressed CD14, accounting for the similar
proportions of IL-12-secreting cells in each population. We
therefore decided to focus our study on CD14
+ cells. Most MLN
CD14
+ cells expressed MHC class II molecules, half expressed
CD11c and only one fifth expressed CD205. Most of the CD14
+
cells also co-expressed CD40 but CD135 (Flt3) was only weakly
expressed.
Transmission electron microscopy demonstrated that neonatal
CD14
+ MLN cells had numerous processes and horseshoe-shaped
nuclei, as expected for cells of the myeloid lineage (Fig. 6A). We
also observed several dark electron-dense granules and a well
developed endosomal compartment resembling that of ovine
monocyte-derived DCs [29] and a CD11b
int/high subpopulation of
bone marrow-derived DCs [30]. Scanning electron microscopy
revealed that neonatal CD14
+ MLN cells had a classical DC
architecture, including a highly convoluted cell membrane and
long dendritic processes (Fig. 6B).
CD14
+ MLN cells differ quantitatively and qualitatively
from those of adults
We investigated the role of CD14
+ cells in IL-12 secretion, by
selecting CD14
2 cells from adult and neonatal MLN cells, by flow
cell sorting, before in vitro stimulation with R-848 for 48 h (Fig. 7A).
CD14
2 MLN cells secreted significantly less IL-12 than total
MLN cells, not only in neonates (8863% inhibition) but also in
adults (9861% inhibition), demonstrating the essential role of
CD14
+ MLN cells in both groups.
Having clearly defined CD14
+ cells as the major population of
IL-12-secreting cells among neonatal and adult MLN cells, we
addressed the question of a possible quantitative defect affecting
adult CD14
+ cells. Indeed, flow cytometry analysis revealed that
the proportion of CD14
+ MLN cells in neonates was twice that in
adults (15.862.1% versus 7.361.2%; Fig. 7B). However, the mean
fluorescence intensity analysis revealed that CD14 was expressed
at a similar level at the surface of adult and neonate CD14
+ cells
(data not shown).
We cultured the same number of neonatal and adult sorted
CD14
+ cells separately, in the presence of R-848, for 48 h.
Neonatal CD14
+ cells secreted IL-12 directly in response to R-848
(Fig. 7C), whereas adult cells displayed a significant defect in
secretory activity, although they were able to secrete some IL-12
directly. Thus, quantitative and qualitative differences affecting
CD14
+ cells from neonates and adults were responsible for the
strong neonatal IL-12 response to R-848.
Higher levels of p38/MAPK phosphorylation in neonatal
CD14
+ cells stimulated with R-848
We then investigated possible differences between neonates and
adults in terms of TLR expression on the surface of CD14
+ cells.
The recognition of R-848 by human immune cells is mediated by
both TLR7 and TLR8 [31], whereas the recognition of this
molecule by murine immune cells involves only TLR7 [32]. We
showed, by qRT-PCR analysis, that TLR7 mRNA levels were
very low, and similar in CD14
+ and CD14
2 cells, in both neonates
and adults (Fig. 8A). By contrast, TLR8 mRNA levels were higher
in CD14
+ cells than in CD14
2 cells, in both groups. However, no
significant difference in TLR8 mRNA levels was found between
neonates and adults, suggesting that this difference resulted from
TLR signalling.
We therefore stimulated total MLN cells isolated from neonates
and adults with CL075, which mediates stimulation preferentially
through TLR8, or with CL087, which mediates stimulation
Figure 3. MLN and spleen cell IL-12 responses to R-848
stimulation as a function of age. MLN and spleen cells from 6- to
14-day-old neonates (closed circles), 20-day-old lambs (closed dia-
monds) and adults (open squares) were cultured in vitro for 48 h, with
or without 0.5 mg/ml R-848. At the end of the culture period,
supernatants were harvested and ELISA carried out to assess IL-12
secretion by MLN cells (A) or spleen cells (B). Medians are shown for
each stimulus. Non-parametric Mann-Whitney tests were used to
compare data for neonates, 20-day-old lambs and adults: *p#0.01;
**p#0.005; ***p#0.001; ****p#0.0005.
doi:10.1371/journal.pone.0013705.g003
Age-Dependent Response to R848
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ruminant species more precisely. Neonatal MLN cells secreted
more IL-12 than adult MLN cells in response to R-848, but also in
the presence of CL075 and CL087 (Fig. 8B). However, both
groups sensed CL075 similarly to R-848 and significantly better
than CL087, indicating a preferential role of TLR8 rather than
TLR7 in the recognition of R-848 by ovine immune cells.
We next analysed the levels of SOCS-1 and SOCS-3, two
proteins shown to regulate TLR signalling indirectly in innate
immune cells [33]. We found that the levels of mRNA encoding
SOCS-1 and SOCS-3 were upregulated as soon as 3 h after
stimulation with R-848 in neonatal MLN cells, but not in adult
MLN cells (data not shown). These findings were confirmed in
neonatal and adult CD14
+ cells (Fig. 8C). SOCS-1 and SOCS3
proteins could be produced to regulate R-848 response but this
could not explain the difference in IL-12 response between
neonates and adults. We therefore analysed the phosphorylation of
p38/MAPK, which has been identified as a key signalling
molecule downstream from R-848/TLR8 activation. We also
confirmed p38 MAPK implication in IL-12 production in
response to R-848 in ovine cells. Indeed, when p38/MAPK
inhibitor SB203580 was added to R-848 stimulated MLN cells, the
level of IL-12 produced was reduced by 41.367.5% (p,0.005).
Western blots showed that neonatal CD14
+ cells displayed higher
rates of phosphorylation than their adult counterparts 15 minutes
after stimulation with R-848, these rates being even higher after 30
minutes (Fig. 8D).
Discussion
Several studies have focused on the specific features of the
neonatal response to TLR agonists. Most were performed on
human cord blood cells or mouse spleen cells. In this study, we
aimed to extend this knowledge to mesenteric lymph node cells, as
they represent a key site not only for the induction of tolerance to
food proteins but also for the induction of specific immune
responses against intestinal pathogens. Moreover, they act as a
firewall, preventing live commensal intestinal bacteria from
penetrating the systemic immune system [34].
Our ELISA data show that MLN cells from newborn lambs have
a strong IL-12 response to R-848. The antibodies used for the IL-12
ELISA cannot distinguish between the bioactive IL-12p70 from the
IL-12p40 subunit. The p40 chain can be produced as monomer,
associated to p19 chain to form IL-23 or as an antagonist IL-12p40
homodimer (IL-12p80). However, as we also observed high levels of
IFNc releaseby MLN neonatal cellsthat canbe severely reduced by
in vitro IL-12 neutralisation, this suggests that neonate produce more
bioactive IL-12p70. Moreover, qRT-PCR and ELISA time courses
confirmed that IL-12 production preceded IFNc gene expression.
We therefore focused on the reasons for this difference in IL-12
production between neonates and adults. CD14
+ cells were
identified, by intracellular staining and in vitro depletion, as the
main population producing IL-12 in response to the in vitro
stimulation of MLN cells with R-848.
In our study, MLN CD14
+ cells co-expressed the myeloid
markers CD11b and CD40, but not CD135 (Flt3). Electron
microscopy showed these cells to have several characteristics of
DCs, such as long dendritic processes, electron-dense granules and
a well developed endosomal compartment. Ovine DCs have been
well characterised in afferent lymph [23,35] and when derived in
Figure 4. Roles of TGFb1 and IL-10 in regulating IL-12 responses to R-848. MLN cells from neonates (closed circles) and adults (open
squares) were cultured in vitro for 48 h, with or without 0.5 mg/ml R-848, in the presence of rhTGFb1 (n=7) (A) or rovIL-10 (n=5) (B). Supernatants
were harvested and ELISA was carried out to assess IL-12 secretion. The mean 6 SEM level of IL-12 secretion is shown (A, B). RNA was extracted and
purified from freshly isolated MLN cells. IL-10 mRNA levels were determined by quantitative RT-PCR. Median normalised values are presented for
neonates (closed circles) and adults (open squares) (C). MLN cells from neonates (closed circles) and adults (open squares) were stimulated in vitro for
48 h with or without 0.5 mg/ml R-848. Supernatants were harvested and ELISA carried out to assess IL-10 secretion. Medians are indicated. Non-
parametric Mann-Whitney tests were used to compare data for neonates and adults: **p#0.001 (D). RNA was extracted and purified from freshly
isolated MLN cells. Foxp3 mRNA levels were determined by quantitative RT-PCR. Median normalised values are presented for neonates (closed circles)
and adults (open squares) (E). Comparison of the IL-12 response of neonate MLN cells to R-848 stimulation in culture medium supplemented with
10%FCS, 10% neonate autologous plasma or 10% adult plasma. Paired t-test between neonate and adult plasma were non-significant (F).
doi:10.1371/journal.pone.0013705.g004
Figure 5. Main cell population producing IL-12 in response to
R-848. Neonatal MLN cells were cultured in vitro with or without
0.5 mg/ml R-848 and, at various time points, supernatants were
harvested and ELISA was carried out for IL-12. Mean 6 SEM IL-12
secretion is shown for each time point (A). Neonatal MLN cells were
cultured in vitro with (black bars) or without (hatched bars) 0.5 mg/ml R-
848 for 8 h, with brefeldin A added for the last 5 h. Cells were harvested
for IL-12 intracellular staining combined with labelling of CD11b, CD14,
MHC class II and CD205. Three independent experiments were carried




+, MHC class II
+ or CD205
+ MLN cells (B).
doi:10.1371/journal.pone.0013705.g005
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in lymph nodes have yet to be described. In PBMCs from humans
and cattle, CD14
+ cell depletion abolishes the IL-12 response to R-
848 [17,36]. Our results based on phenotypic and morphological





2 cells are a subpopulation of myeloid DCs that develop
from blood monocytes independently of the Flt3 ligand.
The difference in the IL-12 response between neonatal and
adult MLN cells may result from several factors, including a
difference in the number of CD14
+ cells, qualitative differences
and/or environmental factors affecting the response of these cells.
Higher or lower frequencies of immune cell populations in the
blood or organs of neonates are commonly reported. As
differences in the frequency of CD14
+ cells among MLN cells
may directly modify the amount of IL-12 produced in response to
TLR stimulation, we analysed the proportions of these cells in
both adults and neonates. CD14
+ cells accounted for a higher
proportion of MLN cells in neonates, and this proportion rapidly
decreased with age, from 16% in one- to two-week-old animals to
10% in 20-day-old lambs and finally reaching 7% in adult
animals.
This may directly contribute to the strong IL-12 response to R-
848 of neonatal MLN cells. However, we also observed that
isolated neonatal CD14
+ cells were more responsive than their
adult counterparts to imidazoquinoline compounds. R-848 binds
TLR7 and TLR8, but the responses to this binding differ between
animal species [32]. Our results, obtained with the more specific
TLR7 and TLR8 agonists, CL087 and CL075, respectively,
suggest that TLR8 was the principal receptor involved in the IL-12
response to R-848 in ovine cells, consistent with previous findings
for cattle PBMCs [17]. This conclusion is supported by the
preferential expression of TLR8, which is present at much higher
levels than TLR7, on CD14
+ MLN cells.
However, the level of TLR8 expression is similar on neonatal
and adult CD14
+ cells, suggesting that the difference in response to
R-848 between neonates and adults depends on other differences
affecting regulation by external or intracellular cytokines or by
signalling events downstream from TLR8.
Figure 6. CD14
+ morphology on microscopy. Two representative pictures of neonatal CD14
+ MLN cells observed by transmission electron
microscopy (A, top panels). Two representative pictures of scanning electron microscopy after overnight culture of neonatal CD14
+ MLN cells on
glass coverslips (B, bottom panels). The scale bars on the representative pictures indicate 2 mm.
doi:10.1371/journal.pone.0013705.g006











81.164.0 47.361.9 2.760.1 82.761.5 8.960.9 21.461.2 38.660.5 62.165.6
Cell surface marker expression by CD14
+ cells (%).
Neonatal MLN cells were double-labelled with a primary mouse antibody cross-reacting with CD14 and another antibody cross-reacting with or specific for sheep cell-
surface markers: CD11b, CD11c, CD26, CD40, CD135, CD205, CD206 or MHC class II molecules. The table shows mean 6 SEM percentages of cells positive for the various
markers tested among the gated CD14
+ cells. Three independent experiments were performed.
doi:10.1371/journal.pone.0013705.t001
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regulatory cytokine IL-10. In mouse, neonatal splenic regulatory B
cells (Breg) expressing CD5 have been shown to produce large
amounts of IL-10 in response to the in vivo administration of TLR
agonists that significantly decrease IL-12 production [13,37].
Similarly, Booth et al. observed that sheep Peyer’s patch cells
displayed poor IFNc, IFNa and IL-12 responses to CpG but
secreted large amounts of IL-10. By depleting the CD5
2 CD21
+
B-cell population or neutralising IL-10, these authors obtained a
significant increase in the CpG-induced IFNc response, suggesting
that IL-10 from this Breg cell population may regulate the immune
response in Peyer’s patches [38]. However, MLN cells in the same
conditions produced five to 10 times more IL-12 than Peyer’s
patch cells. As we observed that only neonatal MLN cells
produced low amounts of IL-10 in response to R-848, Breg are
unlikely to be involved in the difference in cytokine response
observed between neonates and adults in our experimental model.
Moreover, we observed that the CD14
+ population responsible for
the strong IL-12 response in neonates also produced most, if not
all of the low amount of IL-10 released after R-848 stimulation
(data not shown). Treg constitute a population of adaptive immune
system cells that can regulate both innate and adaptive immune
responses by secreting cytokines (e.g. IL-10 and TGFb1) and by
cell-cell contact. Nevertheless, we observed that Foxp3 levels did
not differ significantly between neonates and adults in the MLN
and that rhTGFb1, despite its cross-reactivity with ovine cells,
Figure 7. Role of CD14
+ cells in IL-12 secretion in response to R-848 stimulation. Neonatal (closed circles) and adult (open circles) total MLN
cells and CD14
2 cells (closed and open squares, respectively) were cultured in vitro for 48 h with 0.5 mg/ml R-848. Supernatants were harvested and
ELISA was carried out to assess IL-12 secretion. Paired t-tests were used: *p#0.01; ***p#0.0001 (A). The percentage of CD14
+ cells in 6- to 14-day-old
neonatal (closed circles) and adult (open squares) MLN cells was assessed by single staining and flow cytometry (B). Sorted CD14
+ MLN cells from 6-
to 14-day-old neonates (closed diamonds) or adults (open diamonds) were cultured in vitro for 48 h with 0.5 mg/ml R-848. Supernatants were
harvested and ELISA was carried out to assess IL-12 secretion (C). Non-parametric Mann-Whitney tests were used to compare data for neonates and
adults: *p#0.01; **p#0.005 (A–C).
doi:10.1371/journal.pone.0013705.g007
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848. We next investigated the expression of TLR-induced negative
regulatory molecules SOCS in the response of neonatal and adult
MLN cells to R-848. CD14
+ MLN cells from neonates strongly
upregulated IL-12/23 chain p40, which was much more abundant
than in adults by 3 h after stimulation with R-848. This was
Figure 8. Intracellular signalling upon TLR8 ligation: p38/MAPK phosphorylation. RNA was extracted and purified from sorted CD14
+ and
CD14
2 MLN cells from neonates (closed bars) and adults (open bars). TLR7 and TLR8 mRNA levels were determined by quantitative RT-PCR. Mean 6
SEM normalised values for TLR expression are shown. Paired t-tests were used to compare TLR7 and TLR8 expression by CD14
+ and CD14
2 MLN cells:
*p#0.05; ***p#0.001 (A). MLN cells from neonates (closed circles) and adults (open squares) were cultured in vitro for 48 h, with or without 0.5 mg/ml
R-848, CL075 or CL087. Supernatants were harvested and ELISA was carried out for IL-12. Medians are shown for each stimulus. Paired t-tests were
used to compare IL-12 secretion to different TLR agonists for both neonates and adults: *p#0.05; **p#0.005; ***p#0.0001 (B). RNA was extracted
and purified from sorted CD14
+ MLN cells from neonates (black bars) and adults (white bars), 3 h after stimulation with R-848. IL-12/IL-23p40, SOCS-1
and SOCS-3 mRNA levels were determined by quantitative RT-PCR, as described above (C). Lysates of 1610
6 CD14
+ MLN cells from neonates (n=4)
and adults (n=3) were analysed, after 15 or 30 minutes of stimulation with R-848, by western blotting for pp38 and total p38. Representative images
are shown, with corresponding quantification of pp38 with respect to total p38 protein (D).
doi:10.1371/journal.pone.0013705.g008
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SOCS-3 mRNA. This suggests that these regulatory molecules
(IL-10, SOCS-1 and SOCS-3) are produced to downregulate
inflammatory signals induced strongly in neonatal but only poorly
in adult CD14
+ cells. We then investigated whether signalling
events downstream from TLR8 ligation could account for the
difference in IL-12 response between neonates and adults. The
exposure of human neonatal or adult APCs to TLR8 agonists has
been reported to induce the robust phosphorylation of p38/
MAPK and the prolonged degradation of IkBa? resulting in the
robust induction of Th1-type immune responses, including the
production of IL-12 and the upregulation of costimulatory
molecule CD40 [39]. The level of p38/MAPK phosphorylation
rate was higher in neonatal CD14
+ cells stimulated with R-848
than in their adult counterparts.
The rapid weakening of the strong IL-12 response to TLR8
stimulation, observed from 20 days onwards in the MLN, is due to
the combination of both a change in the number of CD14
+ cells
and qualitative differences in downstream intracellular signalling
pathways. Indeed, despite the production of IL-10 and the
upregulation of SOCS-1 and SOCS-3 mRNA, neonatal CD14
+
MLN cells still display higher levels of p38/MAPK phosphoryla-
tion than their adult counterparts. This stronger phosphorylation
of p38/MAPK in neonates could result as a consequence of
stronger downstream TLR8 activation signals or preferential
phosphorylation of p38/MAPK in neonates. Whatever the
reasons, as already reported in humans, imidazoquinoline
compounds are also powerful stimulators of the innate immune
system of neonatal lambs that could be considered for use in early
mucosal vaccination strategies.
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